Information:
Fel:
ID
28337
Beskrivning
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma Visit: All Visits Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz
Nyckelord
Versioner (5)
- 2017-11-30 2017-11-30 -
- 2017-11-30 2017-11-30 -
- 2017-12-07 2017-12-07 -
- 2017-12-10 2017-12-10 -
- 2018-01-04 2018-01-04 -
Rättsinnehavare
Prof. Dr. med. Georg Heß
Uppladdad den
4 januari 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Signature GOAL Trial B-cell Lymphoma NCT02499003
Signature GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Similar models
Signature GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Subject ID
Item
Subject ID
text
C2348585 (UMLS CUI [1])
confirmation patient information
Item
I have reviewed this eCRF and confirm that, to the best of my knowledge, it accurately reflects the study information obtained for this patient. All entries were made either by me or by a person under my supervision who has signed the Delegation and Signature Log
boolean
C0521091 (UMLS CUI [1,1])
C1955348 (UMLS CUI [1,2])
C1955348 (UMLS CUI [1,2])
Date of signature
Item
Date of signature
date
C0807937 (UMLS CUI [1])
Name of investigator
Item
Name of investigator
text
C2826892 (UMLS CUI [1])
Inga kommentarer